Bone marrow osteoblast damage by chemotherapeutic agents.
Hematopoietic reconstitution, following bone marrow or stem cell transplantation, requires a microenvironment niche capable of supporting both immature progenitors and stem cells with the capacity to differentiate and expand. Osteoblasts comprise one important component of this niche. We determined...
Main Authors: | Stephanie L Rellick, Heather O'Leary, Debbie Piktel, Cheryl Walton, James E Fortney, Stephen M Akers, Karen H Martin, James Denvir, Goran Boskovic, Donald A Primerano, Jeffrey Vos, Nathanael Bailey, Marieta Gencheva, Laura F Gibson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3281873?pdf=render |
Similar Items
-
Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia
by: Debbie Piktel, et al.
Published: (2022-05-01) -
Chemotherapeutic Activity of Pitavastatin in Vincristine Resistant B-Cell Acute Lymphoblastic Leukemia
by: Debbie Piktel, et al.
Published: (2023-01-01) -
Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells
by: Elise Aasebø, et al.
Published: (2021-05-01) -
Programmed conversion of hypertrophic chondrocytes into osteoblasts and marrow adipocytes within zebrafish bones
by: Dion Giovannone, et al.
Published: (2019-02-01) -
Lnc000727 promotes differentiation of human bone marrow mesenchymal stem cells into osteoblasts
by: PU Chao, ZHANG Shan-shan, WU Qing-xia, LUO Xu-wei, WANG Liang, ZHANG Bo
Published: (2022-07-01)